Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Expected to Announce Quarterly Sales of $3.12 Million

Analysts predict that Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Rating) will announce $3.12 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Accelerate Diagnostics’ earnings, with the lowest sales estimate coming in at $2.90 million and the highest estimate coming in at $3.33 million. Accelerate Diagnostics […]

Related Keywords

Jackw Schuler ,Hany Massarany ,Craig Hallum ,William Blair ,Daiwa Securities Group Inc ,Squarepoint Ops ,Diagnostics Inc ,Zacks Investment Research ,Citigroup Inc ,Capital Advisors Inc ,Nasdaq ,Accelerate Diagnostics ,Get Rating ,Accelerate Diagnostic ,Investment Research ,Director Hany Massarany ,Director Jack ,Securities Group ,Nasdaq Axdx ,Axdx ,Medical ,Ratings ,Consensus ,